M. YILMAZ Et Al. , "Lung cancer risk and MDM2 T309G polymorphism in a Turkish population," III Anticancer Agent Development Congress , İzmir, Turkey, 2015
YILMAZ, M. Et Al. 2015. Lung cancer risk and MDM2 T309G polymorphism in a Turkish population. III Anticancer Agent Development Congress , (İzmir, Turkey).
YILMAZ, M., TAŞ, A., KAÇAN, T., SARİ, İ., & SİLİĞ, Y., (2015). Lung cancer risk and MDM2 T309G polymorphism in a Turkish population . III Anticancer Agent Development Congress, İzmir, Turkey
YILMAZ, MERAL Et Al. "Lung cancer risk and MDM2 T309G polymorphism in a Turkish population," III Anticancer Agent Development Congress, İzmir, Turkey, 2015
YILMAZ, MERAL Et Al. "Lung cancer risk and MDM2 T309G polymorphism in a Turkish population." III Anticancer Agent Development Congress , İzmir, Turkey, 2015
YILMAZ, M. Et Al. (2015) . "Lung cancer risk and MDM2 T309G polymorphism in a Turkish population." III Anticancer Agent Development Congress , İzmir, Turkey.
@conferencepaper{conferencepaper, author={MERAL YILMAZ Et Al. }, title={Lung cancer risk and MDM2 T309G polymorphism in a Turkish population}, congress name={III Anticancer Agent Development Congress}, city={İzmir}, country={Turkey}, year={2015}}